Harmony Biosciences officer reports equity holdings
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Harmony Biosciences Holdings, Inc. reports that officer Stephen M. Mollichella, whose title is listed as "INT PRINCIAL FINANCIAL OFFICER", beneficially holds stock options over 12,172, 8,500, 7,050 and 20,750 shares of common stock with exercise prices from 30.6900 to 38.0100, expiring between 2031 and 2036. He also holds restricted stock units over 2,625, 3,488 and 5,900 shares that vest in annual installments beginning in 2027, subject to continued service, and 2,506 shares of common stock directly.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Mollichella Stephen M.
Role
INT PRINCIAL FINANCIAL OFFICER
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option F1 | -- | -- | -- |
| holding | Stock Option F2 | -- | -- | -- |
| holding | Stock Option F3 | -- | -- | -- |
| holding | Stock Option F4 | -- | -- | -- |
| holding | Restricted Stock Unit F5 | -- | -- | -- |
| holding | Restricted Stock Unit F6 | -- | -- | -- |
| holding | Restricted Stock Unit F7 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option — 48,472 contracts (Direct);
Restricted Stock Unit — 12,013 contracts (Direct);
Common Stock — 2,506 shares (Direct)
Footnotes (7)
- F1. The stock option vests with respect to 50% of the underlying shares on July 13, 2023, with the remaining shares vesting ratably on a monthly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- F2. The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- F3. The stock option vests with respect to 25% of the underlying shares on January 25, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- F4. The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- F5. The outstanding restricted stock units shall vest in two equal annual installments beginning on January 24, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
- F6. The outsanding restricted stock units shall vest in three equal annual installments beginning on January 25, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
- F7. The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
Key Figures
Common stock held directly: 2506.0000 shares
Stock option underlying shares: 12172.0000 shares
Stock option underlying shares: 8500.0000 shares
+5 more
8 metrics
Common stock held directly
2506.0000 shares
Directly owned Harmony Biosciences common stock as of the Form 3 report
Stock option underlying shares
12172.0000 shares
Underlying common shares for stock option at exercise price 37.4600, expiring 2031-07-19
Stock option underlying shares
8500.0000 shares
Underlying common shares for stock option at exercise price 30.6900, expiring 2034-01-24
Stock option underlying shares
7050.0000 shares
Underlying common shares for stock option at exercise price 38.0100, expiring 2035-01-25
Stock option underlying shares
20750.0000 shares
Underlying common shares for stock option at exercise price 36.7600, expiring 2036-01-22
Restricted stock units
2625.0000 shares
RSUs vest in two equal annual installments beginning on 2027-01-24, subject to continued service
Restricted stock units
3488.0000 shares
RSUs vest in three equal annual installments beginning on 2027-01-25, subject to continued service
Restricted stock units
5900.0000 shares
RSUs vest in four equal annual installments beginning on 2027-01-22, subject to continued service
Key Terms
Stock Option, Restricted Stock Unit, vesting, grant date
4 terms
Stock Option financial
"The stock option vests with respect to 50% of the underlying shares on July 13, 2023"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Restricted Stock Unit financial
"The outstanding restricted stock units shall vest in two equal annual installments"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
vesting financial
"with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
grant date financial
"thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity holdings did HRMY officer Stephen M. Mollichella report on his Form 3?
Stephen M. Mollichella reported stock options over 12,172, 8,500, 7,050 and 20,750 HRMY shares, restricted stock units over 2,625, 3,488 and 5,900 shares, and 2,506 shares of common stock held directly.
What are the exercise prices and expirations of Stephen M. Mollichella’s HRMY stock options?
Mollichella holds stock options with exercise prices of 37.4600, 30.6900, 38.0100 and 36.7600 per share, expiring on 2031-07-19, 2034-01-24, 2035-01-25 and 2036-01-22, respectively.
How do the HRMY restricted stock units reported by Stephen M. Mollichella vest?
Mollichella’s HRMY restricted stock units over 2,625 shares vest in two equal annual installments from January 24, 2027; 3,488 shares vest in three equal annual installments from January 25, 2027; and 5,900 shares vest in four equal annual installments from January 22, 2027, all subject to continued service.
What role does Stephen M. Mollichella hold at Harmony Biosciences (HRMY) in this ownership report?
In the ownership report, Stephen M. Mollichella is identified as an officer of Harmony Biosciences with the title "INT PRINCIAL FINANCIAL OFFICER", and the filing details his existing stock options, restricted stock units and direct common stock holdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates